Novartis Stockpiles: Pharma Braces for Potential US Tariffs

Is your medicine cabinet safe from Trump's tariffs? Novartis CEO reveals the company's secret plan to stockpile drugs in the U.S. until 2026, bracing for a potential 250% tariff hike. Find out how this pharma giant is spending billions to shift manufacturing to America, and what it means for the future of drug prices and availability. Don't miss this insider look at the high-stakes game being played between Big Pharma and Washington. Hosted on Acast. See acast.com/privacy for more information.